1-4 of 4
Nurulhuda Mustafa, PhD
Close
Sort by
Journal Articles

CD55 and CD59 Can Limit the Anti-Tumor Efficacy of Daratumumab in Natural Killer/T-Cell Lymphoma

Nurulhuda Mustafa, PhD, Adina Huey Fang Nee, BSc, Jing Yuan Chooi, BSc, Sabrina Hui Min Toh, BSc, Yan Ting Hee, BSc, Viknesvaran Selvarajan, PhD, Longen Zhou, PhD, Jennifer Yang, PhD, Wee Joo Chng, MB ChB, PhD FRCP(UK), FRCPath, FAMS
Journal: Blood
Blood (2018) 132 (Supplement 1): 1663.
https://doi.org/10.1182/blood-2018-99-115566
Published: 2018
Journal Articles

Daratumumab Efficiently Targets NK/T Cell Lymphoma with High CD38 Expression

Nurulhuda Mustafa, PhD, Huey Fang Adina Nee, BSc, Xue Ting Jeannie Lee, BSc, Wei Jin, PhD, Yiling Yu, PhD, Yingnan Chen, PhD, Jennifer Yang, PhD, Wee Joo Chng, MB ChB, MRCP, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 2814.
https://doi.org/10.1182/blood.V130.Suppl_1.2814.2814
Published: 2017
Journal Articles

MMSET Regulates IRF4, a Transcription Factor Critical for the Survival of T(4;14) Myeloma Myeloma Cells, and Its Silence Potentiates the Effect of Antimyeloma Agents

Zhigang Xie, PhD, Chonglei Bi, B.S, Jing Yuan Chooi, B.S, Zit Liang Chan, B.S, Nurulhuda Mustafa, PhD, Wee Joo Chng, MD PhD
Journal: Blood
Blood (2014) 124 (21): 171.
https://doi.org/10.1182/blood.V124.21.171.171
Published: 2014
Journal Articles

A Novel and Highly Selective Dual PI3K/mTOR Kinase Inhibitor VS-5584, Shows Promising Therapeutic Potential For The Treatment Of Multiple Myeloma

Nurulhuda Mustafa, PhD, Biomedical Science, Stefan Hart, PhD, Wee-Joo Chng
Journal: Blood
Blood (2013) 122 (21): 4433.
https://doi.org/10.1182/blood.V122.21.4433.4433
Published: 2013